Announcements
Investor News
BioPorto A/S
Første 6 måneder af 2024: Fortsat stærk vækst i salget af NGAL-tests i USA og fokuseret eksekvering af alle elementer i BioPortos strategi
Thu, 15 Aug 2024 06:58 GMT
BioPorto A/S
BioPorto Announces Interim Results and Business Update for the Second Quarter and Six Months of Fiscal 2024
Thu, 15 Aug 2024 06:37 GMT
BioPorto A/S
BioPorto A/S to Host Second Quarter 2024 Earnings Webcast & Investor Meeting
Wed, 07 Aug 2024 11:04 GMT
BioPorto A/S
BioPorto Announces NIH-Funded Study to Explore the Ability of Renal Biomarkers in Predicting Severe AKI, Advancing Beyond NLP-based AI Algorithms
Tue, 30 Jul 2024 15:15 GMT
BioPorto A/S
BioPorto to Debut FDA Approved ProNephro AKI at Upcoming ADLM 2024 Clinical Lab Expo
Mon, 29 Jul 2024 14:35 GMT